AbbVie (NYSE:ABBV) is scheduled to announce Q4 earnings results on Friday, February 7th, before market open.
The consensus EPS Estimate is $2.19 (+15.3% Y/Y) and the consensus Revenue Estimate is $8.68B (+4.5% Y/Y).
Over the last 2 years, ABBV has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time.
Over the last 3 months, EPS estimates have seen 6 upward revisions and 2 downward. Revenue estimates have seen 5 upward revisions and 3 downward.
https://seekingalpha.com/news/3539307-abbvie-q4-2019-earnings-preview
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.